SGEN Financial Facts

Revenue from collaboration and license agreements: 20.18M
Income (loss) from operations: -21.02M
See Full Income Statement

Current portion of deferred revenue: 39.33M
Total assets: 879.39M
See Full Balance Sheet

Seattle Genetics Inc. (SGEN) Earnings

  |   Expand Research on SGEN
Next EPS Date 8/1/16 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -27.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/28/16 Q116 -$0.15-$0.09 -$0.06$111.2M$116.49M N/A Details
2/9/16 Q415 -$0.18-$0.20 +$0.02$93.5M$88.28M N/A Details
10/29/15 Q315 -$0.21-$0.20 -$0.01$84.1M$82.67M N/A Details
7/30/15 Q215 -$0.38-$0.26 -$0.12$77.1M$77.97M N/A Details
2/10/15 Q414 -$0.22-$0.25 +$0.03$74.3M$68.34M N/A Details
10/30/14 Q314 -$0.13-$0.24 +$0.11$75.8M$66.9M N/A Details
7/31/14 Q214 -$0.14-$0.23 +$0.09$68.3M$65.04M N/A Details
5/1/14 Q114 -$0.13-$0.21 +$0.08$68.3M$64.62M N/A Details